Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T05:00:13.344Z Has data issue: false hasContentIssue false

Effect of Dietary Phenylalanine Restriction On Visual Attention Span In Mentally Retarded Subjects With Phenylketonuria

Published online by Cambridge University Press:  18 September 2015

F.D. Giffin
Affiliation:
Department of Pediatrics, The Atlantic Research Centre for Mental Retardation, Dalhousie University, and Department of Psychology, lzaak Walton Killam Hospital for Children, Halifax, Nova Scotia
J.T.R. Clarke*
Affiliation:
Department of Pediatrics, The Atlantic Research Centre for Mental Retardation, Dalhousie University, and Department of Psychology, lzaak Walton Killam Hospital for Children, Halifax, Nova Scotia
D.M. d'Entremont
Affiliation:
Department of Pediatrics, The Atlantic Research Centre for Mental Retardation, Dalhousie University, and Department of Psychology, lzaak Walton Killam Hospital for Children, Halifax, Nova Scotia
*
Department of Pediatrics, Clinical Research Centre, Room C-R1, Dalhousie University, Halifax, Nova Scotia B3H 4H7, Canada
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

An ABA within-subject study design was used to assess the effect of dietary phenylalanine restriction on the visual attention span of three mentally retarded males (9, 15, and 21 years old)with phenylketonuria. Visual attention span was measured by recording the amount of time the subjects visually fixated pictures projected on a screen according to a standardized test protocol. After 4-6 weeks of baseline testing (A-phase), each subject was placed on a phenylalaninerestricted diet, designed to maintain plasma phenylalanine levels at 0.3 - 0.9 mM, for 8-14 weeks (B-phase). A return to baseline phenylalanine intake (A-phase) was achieved by surreptitiously adding sufficient L-phenylalanine to the therapeutic diets to increase plasma concentrations of the amino acid to pretreatment levels. Diet treatment (B-phase) was associated with highly significant improvementsin visual attention span in two subjects (multivariate analysis of variance, P <<0.001); the third subject, the most retarded, showed no effect. No objectivelydemonstrable change in behavior was documented in any subject. However, the results support the view that phenylalanine toxicity extends beyond early childhood and that some component of the toxicity is reversible, even in severely retarded patients with phenylketonuria.

Type
Research Article
Copyright
Copyright © Canadian Neurological Sciences Federation 1980

References

REFERENCES

Anderson, V., Siegel, E. and Bruhl, H., (1976). Behavioral and biochemical correlates of diet change in phenylketonuria. Pediatr. Res., 10, 1017.CrossRefGoogle ScholarPubMed
Armstrong, M.D., Low, N.L. and Bosma, J.F. (1957). Studies on phenylketonuria IX. Further observations on the effect of phenylalanine-restricted diet on patients with phenylketonuria. Am. J. Clin. Nutr., 5, 543554.CrossRefGoogle ScholarPubMed
Bentovim, A. (1968). Controlled observations of phenylketonuric children on and during withdrawal from low-phenylalanine diet. Arch. Dis. Child., 43, 745746.Google Scholar
Bickel, H. and Grubel-Kaiser, S. (1971). Über die Phenylketonurie. Dtsch. Med. Wochenschr., 96, 14151423.CrossRefGoogle Scholar
Brown, E.S. and Warner, R. (1976). Mental development of phenylketonuric children on or off diet after the age of six. Psychol. Med., 6, 287296.CrossRefGoogle ScholarPubMed
Bruhl, H., Arneson, J. and Bruhl, M. (1965). Effect of a low-phenylalanine diet on older phenylketonuric patients. Am. J. Ment. Defic, 69, 225235.Google Scholar
De Wolfe, M.S., Baskurst, S. and Cochrane, W.A. (1967). Automatic amino acid analysis of blood serum and plasma. Clin. Biochem. 1, 7581.CrossRefGoogle Scholar
Fantz, R.L. (1965). Visual perception from birth as shown by pattern selectivity. Ann. N.Y. Acad. Sc., 118, 793814.CrossRefGoogle ScholarPubMed
Frankenburg, W.K., Goldstein, A.D. and Olsen, CD. (1973). Behavioral consequences of increased phenylalanine intake by phenylketonuric children: A pilot study describing a methodology. Am. J. Ment. Defic., 77, 524532.Google ScholarPubMed
Holtzman, N.A., Welcher, D.W. and Mellits, E.D. (1975). Termination of restricted diet in children with phenylketonuria: A randomized controlled study. New Engl. J. Med., 293, 11211124.CrossRefGoogle ScholarPubMed
Horner, F.A., Streamer, C.W., Alejandrino, L.L., Reed, L.H. and Ibbott, F. (1962). Termination of dietary treatment of phenylketonuria. New Engl. J. Med., 266, 7981.CrossRefGoogle ScholarPubMed
Kang, E.S., Solle, N.D. and Park, S.G. (1970). Results of treatment and termination of the diet in phenylketonuria (PKU). Pediatrics, 46, 881890.CrossRefGoogle ScholarPubMed
Koff, E., Kammerer, B., Boyle, P. and Pueschel, S.M. (1979). Intelligence and phenylketonuria: Effects of diet termination. J. Pediatr., 94, 534537.CrossRefGoogle ScholarPubMed
Marholin, D. II, Pohl, R.E. III, Stewart, R.M.Touchette, P.E., Townsend, N.M. and Kolodny, E.H. (1978). Effects of diet and behavior therapy on social and motor behavior of retarded phenylketonuric adults: An experimental analysis. Pediatr. Res., 12, 179187.CrossRefGoogle ScholarPubMed
Miranda, S.B., Hack, M., Fantz, R.L., Fanaroff, A.S. and Klaus, M.H. (1977). Neonatal pattern vision: A predictor of future mental performance. J. Pediatr., 91, 642647.CrossRefGoogle Scholar
Nie, N.H., Hull, CH., Jenkins, J.G., Steinbrenner, K. and Bent, D.H. (1975). Statistical Package for the Social Sciences. Second Edition, pp. 410421. McGraw-Hill, New York.Google Scholar
Smith, L, Lobascher, M.E., Stevenson, J.E., Wolff, O.H.Schmidt, H., Grubel-Kaiser, S. and Bickel, H. (1978). Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria. Br. Med. J., 2, 723726.CrossRefGoogle ScholarPubMed
Solomons, G., Keleske, K. and Opitz, E. (1966). Evaluation of effects of termination of the diet on phenylketonuria. J. Pediatr., 69, 596602.CrossRefGoogle ScholarPubMed